PMC:7128678 / 2765-3280
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
87 | 469-500 | Gene | denotes | angiotensin-converting enzyme-2 | Gene:59272 |
88 | 502-507 | Gene | denotes | ACE-2 | Gene:59272 |
92 | 70-80 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T67 | 70-80 | SP_7 | denotes | SARS-CoV-2 |
T68 | 99-103 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T69 | 225-234 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
T70 | 238-247 | GO:0006897 | denotes | endocytic |
T71 | 278-287 | GO:0005768 | denotes | endosomal |
T72 | 355-363 | CHEBI:36357;CHEBI:36357 | denotes | compound |
T73 | 469-500 | PG_10;PR:000003622 | denotes | angiotensin-converting enzyme-2 |
T74 | 502-507 | G_3;PG_10;PR:000003622 | denotes | ACE-2 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T13 | 278-287 | Body_part | denotes | endosomal | http://purl.org/sig/ont/fma/fma67180 |
LitCovid_AGAC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
p88102s10 | 443-465 | MPA | denotes | terminal glycosylation |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T15 | 70-78 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T16 | 119-120 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T17 | 406-409 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T33 | 99-103 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T34 | 146-155 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T35 | 225-234 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T36 | 345-354 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T37 | 469-480 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 443-465 | http://purl.obolibrary.org/obo/GO_0033578 | denotes | terminal glycosylation |
T4 | 452-465 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T24 | 22-168 | Sentence | denotes | However, the mechanism of action of CLQ against SARS-CoV-2 is unclear as the drug seems to exert a broad range of potential antiviral effects [5]. |
T25 | 169-386 | Sentence | denotes | Therefore, although CLQ is classically considered as an inhibitor of endocytic pathways through elevation of endosomal pH [6], its detailed molecular mechanism of action as an antiviral compound remains unclear [3,5]. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32251731-16439323-48149934 | 165-166 | 16439323 | denotes | 5 |
32251731-29940786-48149935 | 292-293 | 29940786 | denotes | 6 |
32251731-16439323-48149936 | 383-384 | 16439323 | denotes | 5 |
32251731-16115318-48149937 | 510-511 | 16115318 | denotes | 7 |
T79534 | 165-166 | 16439323 | denotes | 5 |
T31422 | 292-293 | 29940786 | denotes | 6 |
T11075 | 383-384 | 16439323 | denotes | 5 |
T4317 | 510-511 | 16115318 | denotes | 7 |